SCHEMBL8890499

SCHEMBL8890499

O=S(=O)(Nc1ccccn1)c1cccc2c(C(F)(F)F)cccc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.62
NSD2 O96028 1/20 0.62
TSHR P16473 1/20 0.62
HSD17B10 Q99714 1/20 0.62
ALDH1A1 P00352 6/20 0.60
MEN1 O00255 3/20 0.60
KMT2A Q03164 3/20 0.60
RXFP1 Q9HBX9 2/20 0.60
HPGD P15428 1/20 0.54
SLC40A1 Q9NP59 3/20 0.51
SLC22A12 Q96S37 2/20 0.50
LMNA P02545 3/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
PKM P14618 2/20 0.48
CASP1 P29466 2/20 0.48
POLB P06746 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
TP53 P04637 1/20 0.48
BRD4 O60885 1/20 0.47
CASP7 P55210 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7768609 0.80 KDM4E (0.67) KDM4ENSD2TSHRHSD17B10ALDH1A1
SCHEMBL16110825 0.71 ALDH1A1 (0.68) KDM4ENSD2TSHRHSD17B10ALDH1A1
SCHEMBL2762847 0.71 SMN1; SMN2 (0.62) KDM4ENSD2TSHRHSD17B10ALDH1A1
SCHEMBL7770284 0.70 RORA (0.54) KDM4ENSD2TSHRHSD17B10LMNA
SCHEMBL11240120 0.70 MEN1 (0.43) KDM4EHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL17559543 0.69 SLC22A12 (0.60) ALDH1A1MEN1KMT2ARXFP1SLC40A1
SCHEMBL29023903 0.69 EDNRA (0.60) KDM4ENSD2TSHRHSD17B10ALDH1A1
SCHEMBL4617033 0.69 ALDH1A1 (0.54) KDM4ENSD2TSHRHSD17B10ALDH1A1
SCHEMBL11217498 0.69 NR1H2 (0.43) KDM4EHSD17B10MEN1KMT2ASLC22A12
SCHEMBL11248862 0.69 TRPV4 (0.42) KDM4EHSD17B10ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5641793-A POSSESS ENDOTHELIN RECEPTOR ANTAGONIST ACTIVITY; USEFUL IN TREATMENT OF HYPERTENSION, CARDIAC OR CEREBRAL CIRCULATORY DISEASE AND RENAL DISEASE ZENECA LIMITED (GB) 1997-06-24 US claimed